A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)-Reference-Cited by-同舟云学术

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

Published:2015-04 Issue:4 Volume:16 Page:316-322
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Ballard Clive,Thomas Alan,Gerry Stephen,Yu Ly-Mee,Aarsland Dag,Merritt Claire,Corbett Anne^ORCID,Davison Christopher,Sharma Narenda,Khan Zunera,Creese Byron,Loughlin Paul,Bannister Carol,Burns Alistair,Win Soe Nyunt,Walker Zuzana

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference34 articles.

1. Alzheimer's Disease International. World Alzheimer Report. 2009. Available at: http://www.alz.co.uk/research/files/WorldAlzheimerReport.pdf. Accessed December 2, 2012.

2. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study;Steinberg;Int J Geriatr Psychiatry,2008

3. National Institute for Health and Clinical Excellence (NICE). Dementia: Supporting people with dementia and their carers in health and social care. Available at: https://www.nice.org.uk/guidance/cg42. 2006. Accessed June 16, 2014.

4. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease;Lyketsos;Am J Geriatr Psychiatry,2006

5. Alzheimer's Society Optimising treatment and care for behavioural and psychological symptoms of dementia: A best practice guide. Available at: http://www.alzheimers.org.uk/bpsdguide. 2012. Accessed April 23, 2014.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease;Expert Opinion on Emerging Drugs;2024-06-11

2. Neuropsychiatric Symptoms (NPS) and Neurocognitive Disorders;Age-Adjusted Psychiatric Treatment for the Older Patient;2024

3. Perspective Chapter - NMDA Treatments for CNS Disorders;Ketamine Revisited - New Insights into NMDA Inhibitors [Working Title];2021-10-28

4. The Development of Pharmacological Therapies for Alzheimer’s Disease;Neurology and Therapy;2021-09-16

5. Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions;Frontiers in Neurology;2021-04-16